Objective. Emergency department (ED) providers are high volume but low quantity prescribers of opioid analgesics (OA). Few studies have examined differences in opioid prescribing decisions specifically among ED providers. The aim of this study was to describe OA prescribing decisions of ED providers at geographically diverse centers, including utilization of prescribing guidelines and prescription drug monitoring programs (PDMP).
Results. The total survey population was 957 individuals and 515 responded to the survey for an overall response rate of 54%. The frequency of respondents who prescribed different types of pain medication was variable between centers. Fifty-nine percent (219/ 369) of respondents were registered to access a PDMP, and 5% (18/369) were not aware whether their state had a PDMP. Forty percent (172/426) of respondents used OA prescribing guidelines, while 24% (103/426) did not, and 35% (151/426) were unaware of prescribing guidelines. Sixteen percent (68/439) of respondents indicated they have prescribed OA to expedite patient discharge, and 12% (54/439) to improve patient satisfaction. No significant differences in OA prescribing decisions were found between groups either by use of PDMP or by guideline adherence.
Introduction
Poisoning is the leading cause of unintentional injury death in the United States, accounting for nearly 44,000 deaths in 2013 [1] . The class of medication contributing to the largest number of poisoning deaths is opioid analgesics (OA). In 2013, the rate of drug poisoning death involving OA was 5.1 per 100,000, more than three times the rate in 1999 when the rate was 1.4 per 100,000 [1] . The rise of OA overdose deaths mirrors a rise in OA pharmaceutical sales, which reflects an increase in opioid prescribing by healthcare practitioners [2] . In 2012, healthcare providers wrote an estimated 259 million prescriptions for OA [3] . Emergency physicians are among the top five medical specialist groups with respect to the number of prescriptions for OA dispensed to patients under 40 years old [4] . Recent data show that emergency physicians are high volume (number of prescriptions written) but low quantity prescribers (number of pills typically prescribed per prescription), and that as a specialist group emergency physicians have trended downward over the past several years in the amount of OA prescribed to their patients [5, 6] .
Pain-related complaints account for a large number of patients seeking care in the ED, with five of the top ten principal reasons for ED visits in 2011 being directly related to pain [7] . Categories of pain include both acute pain, from injury for example, and exacerbations of chronic pain syndromes. For an ED provider, the decision to prescribe an opioid can be very complicated and carries unintended consequences. In providing care, a clinician must balance the growing problem of prescription drug misuse and abuse and the mandate to alleviate suffering [8, 9] . Numerous factors might influence a provider's decision to prescribe an OA and this decision-making process is poorly understood.
There is a growing but still sparse literature describing OA prescribing decisions in EDs. A literature review identified few studies focused on evaluating physicians' understanding and concerns about their opioid prescribing decisions. The majority of these studies focused on primary care providers, with few addressing emergency providers specifically. One study examined the opioid prescribing decisions and use of PDMPs among medical toxicologists, many of who are also emergency physicians, and found that while medical toxicologists were generally aware of PDMPs, many were not using it when prescribing opioids in clinical practice [10] . However, this study did not offer a broad view of emergency medicine practice. Another study of ED physicians found that PDMP use did frequently alter prescribing decisions, but this was a single center study of only 18 providers [11] .
The Centers for Disease Control and Prevention has identified many strategies to combat the epidemic of prescription opioid misuse and death including: use of prescription drug monitoring programs (PDMPs), bystander naloxone programs, better access to substance abuse treatment, laws to deter prescription drug abuse and diversion, and increased healthcare provider accountability [12] . Unfortunately, most of these reduce the consequences of existing opioid misuse, but do not prevent new initiates. This latter effort represents an important aspect of healthcare provider accountability, and entails optimizing the practice of prescribing OA. Various strategies have been proposed, including the use of evidence-based prescribing guidelines, such as the guidelines published by the American College of Emergency Physicians (ACEP) [13] . It has been suggested that such guidelines are helpful for emergency department (ED) providers because persons at greater risk for opioid misuse frequently visit EDs with pain related complaints [14] . While both use of PDMPs and prescribing guidelines are proposed as important tools to impact OA prescribing decisions, and by extension improve appropriate prescribing while minimizing misuse and diversion of opioids, there is a paucity of evidence that assesses either of these tools for such purposes.
The aim of this study was to describe self-reported OA prescribing decisions of ED providers at different centers, including utilization of prescribing guidelines and PDMPs, and to examine the differences among centers. It was hypothesized that no difference would be found in prescribing decisions between clinicians who report using PDMPs and those who do not, and similarly no difference in prescribing decisions related to a clinicians' adherence to prescribing guidelines.
Methods

Study Design and Population
This was a multi-center cross-sectional observational Web-based survey study of 957 ED providers at seven participating centers. The study was conducted between August 2014 and October 2014. Eligible providers included attending emergency physicians, emergency medicine resident physicians, and advanced practice providers (nurse practitioner or physician assistant) who work in the ED. There were no exclusion criteria. Potential respondents were invited to complete a Web-based questionnaire via e-mail.
The Prescribing Opioids Safely in the Emergency Department (POSED) Research Consortium was utilized to conduct the study [6] . The Consortium is comprised of 30 primarily academic medical centers located in 20 states, spanning all four regions of the country, with over two million annual ED visits. A random cluster sample of seven centers was selected from among the 30 total POSED centers. We used a random sort method to select centers for participation. The list of all POSED centers was entered into SAS 9.3 (Cary, NC), which was then randomly sorted and the first seven centers on the list were selected to participate. All of the selected centers in the sample are affiliated with an emergency medicine residency program.
All subjects who participated in the study provided written informed consent prior to completing the questionnaire. The study protocol was reviewed and approved by the coordinating center's institutional review board and did not require individual participating site IRB review.
Survey Content and Administration
The study questionnaire was developed in accordance with methods outlined by Burns et al. [15] . The initial questionnaire was written by the investigators and then iteratively edited through comments and feedback solicited from expert colleagues at other institutions, as well as a biostatistician, for purposes of item generation and improving structure. The questionnaire inquired about demographics, OA prescribing decisions, experience using PDMPs and opioid prescribing guidelines, and attitudes pertaining to OA prescribing and the prescription opioid epidemic. It was pilot tested using emergency physicians with a similar demographic to the potential respondents to improve question clarity and assist with item reduction. Formal psychometric testing of the questionnaire was not performed.
The survey questionnaire was hosted online and administered using FluidSurveys (http://www.fluidsurveys. com). Points of contact (POCs) for each participating center were identified to coordinate distribution of e-mail announcements containing hyperlinks to the survey questionnaire and to determine the total number of eligible providers at each center. Respondents completed the survey anonymously.
An e-mail announcing the study was sent to potential respondents at each center by the POC, followed subsequently a few days later by a second e-mail containing a link to the questionnaire. Reminder e-mails were sent periodically to encourage increased participation and response rate. In addition, a nominal incentive was offered to survey respondents in the form of a raffle sweepstakes to win a gift card. The raffle database was independently administered separately from the main study database with no link between the two.
Respondents were asked to indicate whether they would prescribe specific types of pain medication (i.e., acetaminophen, NSAIDs, and/or opioids) in four different case scenarios involving painful complaints. Participants could select multiple medications for each case (e.g., acetaminophen and opioids). Respondents were also asked about how often they prescribe OA for specific reasons (Figure 2 ).
Data Analysis
The survey collected information on respondents' attitudes and prescribing decisions using five-point Likert scale questions. We used chi-square tests of association to assess the relationship between providers' opioid prescription decisions and independent covariates. To facilitate analysis in the presence of sparse tables and zero-cells, we collapsed the Likert scale responses into two likelihood groups: Likely (people who indicated they were likely or very likely to prescribe) and Unlikely/ Neutral (people who indicated that they were neutral, unlikely or very unlikely to prescribe). Respondents were also classified into groups who would prescribe an opioid (alone or in combination with other pain medications) and who would not prescribe opioids at all. Although the data was not complete for every respondent, all available data was used for each analysis. Any missing data was handled using pairwise elimination. There was no indication of bias due to variations in response patterns between respondents. A simple adjustment to the sampling weights was used to account for overall survey non-response. All analyses were completed in SAS 9.3 (Cary, NC) using the specialized survey procedures to account for the cluster sampling design. These procedures account for the clustering within the centers by adjusting the chi-square statistic to properly reflect the loss in precision that comes from the increased homogeneity in the observations within a center.
Results
There were 957 potential respondents total from the seven selected centers, 515 individuals responded to the survey invitation for an overall response rate of 54%. Twenty-four respondents did not consent to participate in the study, and 48 responses were excluded for insufficient data, leaving 443 responses included for analysis. Demographic data is presented in Table 1 . Data was not available regarding the demographics of nonrespondents. Figure 1 shows the results for the case scenarios and the frequency respondents prescribed different types of pain medication categorized by center. In case 1, involving neck pain without fracture following a motor vehicle accident, OA prescribing by institution varied from 2% to 53%. In case 2, involving a scaphoid fracture, OA prescribing varied from 44% to 91%. In case 3, Impact of PDMP/Guidelines on OA Prescribing involving abdominal pain without apparent etiology, OA prescribing varied from 4% to 35%. Only case 4, involving a rib contusion after a fall in the setting of three recent OA prescriptions, showed mostly consistent and low OA prescribing rates, with six centers prescribing 3-5% and one center 12%. Some patterns of OA prescribing for the different case scenarios emerged in the data. For example, centers 4 and 6 appeared to prescribe fewer OA than most other centers regardless of the scenario, while centers 3 and 7 prescribed more. Figure 2 is a summary of the frequency respondents prescribed OA for specific reasons. Sixteen percent (68/ 439) of respondents indicated they prescribe OA to expedite discharge of a patient at least once every five shifts. Twelve percent (54/439) indicated they prescribe OA to improve patient satisfaction at least once every five shifts.
Prescribing Decisions
Use of PDMPs and Prescribing Guidelines
Excluding respondents from Pennsylvania (a study center state where there is no PDMP access for clinicians), 59% (219/369) of respondents were registered to access a state PDMP, and 5% (18/369) were not aware whether their state had a PDMP. Among those registered to use a PDMP, 50% typically use it less than once a shift, 27% use it about once a shift, 20% use it more than once a shift, and 6% indicated they try to use it with every prescription they write. Satisfaction with the state PDMP was rated as: 16% very satisfied, 47% satisfied, 25% neutral, 11% dissatisfied, and 1% very dissatisfied. When respondents were asked if they tried to follow an OA prescribing guideline, 40% (172/426) said yes, 24% (103/426) said no, and 35% (151/426) said they were unaware of any such guidelines. Table 3 lists the guidelines being used by respondents.
Two hypotheses were tested: that there would be no difference in prescribing decisions between those respondents who used PDMPs and those who do not, and similarly no difference in prescribing decisions between respondents who try to follow OA prescribing guidelines and those who do not. Results of the tests are shown in Table 4 . No significant differences in OA prescribing decisions were found between groups either by use of PDMP or by guideline adherence.
Discussion
In this multi-center survey, we showed that self-reported OA prescribing decisions of ED clinicians differed between the sampled centers. There was wide variability across centers in the frequency of OA prescribing for three of the four case scenarios.
We can only speculate as to what underlies these differences between centers, and there are likely many factors at play influencing the prescribing decisions at each center. Several factors have already been implicated in the literature as influencing providers' opioid prescribing decisions: patient race, age, and type of insurance; provider training and experience; availability of PDMPs; and region within the US [11, [16] [17] [18] . One study showed that when faced with identical hypothetical case scenarios, ED physicians' decisions to prescribe opioid medications varied greatly and the same clinical information (for example, a patient requesting a specific drug) could change the likelihood of prescribing in opposite directions for different physicians [19] . It is also likely that a "prescribing culture" exists at each center that is unique and will influence the prescribing decisions.
A notable number of respondents indicated that they would often (at least once every five shifts) prescribe OA to expedite discharge (16%) or improve patient satisfaction (12%). This use of OA for reasons unrelated to medical considerations is extremely concerning. CDC promotes "increased healthcare provider accountability" as a key strategy to combat the prescription drug overdose epidemic [12] . Recognizing that there are external non-medical factors that can influence OA prescribing decisions is important, and interventions intended to encourage appropriate OA prescribing should address these issues. 
NSAID ¼ non-steroidal anti-inflammatory drug
Impact of PDMP/Guidelines on OA Prescribing PDMP use was inconsistent; only 59% of respondents were registered to access their respective state's program. Reasons that respondents reported using a PDMP is consistent with a prior qualitative study of emergency providers [20] . Very few prescribers with PDMP access indicated that they used it consistently for all of their patients. It is unknown if consulting a PDMP every time a provider is considering prescribing OA optimizes prescribing decisions. It is also noteworthy that 5% of respondents were unaware of the existence of a PDMP in their state. At the time of the survey all of the states surveyed except Pennsylvania had a PDMP available for use by prescribers.
A minority (40%) of respondents reported use of OA prescribing guidelines. The most commonly used guidelines among respondents were the ACEP clinical policy, and this is consistent with the study population, which was comprised of emergency care providers. However, this clinical policy focuses on only four broad topics, and is not as directive as other existing guidelines. Some prescribing guidelines suggest, for example, specific maximum duration and dose of OA treatment. Additionally, although guidelines did not appear to influence prescribing decisions overall, this could be because the OA prescribing decisions of ED providers generally involve a small number of pills used for a short duration [6] . It is possible that changing the prescribing decisions of a small number of providers at the extremes would not be reflected in summary data. Moreover, there are other benefits of guidelines that may not be captured by the current survey, such as facilitating a discussion with a patient when he or she requests OA and the provider does not feel a prescription is indicated. It is unclear why only a minority of providers in the sample uses prescribing guidelines. More widespread adoption of guidelines will be important to achieve if such interventions are going to make an impact changing prescribing practices. It is noteworthy that 35% of respondents indicated they were unaware of any OA prescribing guidelines.
Lastly, it is interesting that no associations were found between prescribing decisions and use of PDMPs or OA prescribing guidelines. According to the ACEP clinical policy, "there remains a dearth of evidence about the effectiveness of [prescription drug monitoring programs] in altering physician prescribing patterns or diminishing the adverse effects of opioids in the community" [13] . Our results show neither an association between OA prescribing decisions and PDMP use, nor an association between OA prescribing decisions and guideline use. Indeed, there are myriad NSAID ¼ non-steroidal anti-inflammatory drug; APAP ¼ acetaminophen possibilities for the lack of association found in our results. The clinical vignettes posed in the study questionnaire provided all respondents with the same information; in a real-world situation where PDMP use uncovers additional information about a patient's opioid prescription history, it stands to reason that providers who utilize the PDMP might make different decisions than those who do not. Regarding guideline use, it should be noted that the clinical vignettes used in the questionnaire were not specifically written to test adherence to any particular set of prescribing guidelines. A lack of association between guideline use and prescribing decisions may be due to a lack of specificity in the vignettes. It is also possible that no difference was observed because prescribers are not using these tools in a manner that actually impacts their decision-making, or because the information found in the PDMP was incomplete or difficult to interpret (e.g., duplicate names, incorrect addresses).
We did not assess a provider's impression of the value of the information obtained in the PDMP when it was accessed. Other factors may play a more important role than PDMP information or prescribing guidelines for a provider faced with a decision whether to prescribe OA. Ultimately, these results do not suggest that PDMPs or guidelines are not useful, but rather that further research is needed to elucidate best practices for using PDMP data and to better focus future guidelines.
Limitations
This survey involves self-reporting of decisions by respondents and may be confounded by both social desirability bias and recall bias. Impact of PDMP/Guidelines on OA Prescribing and the representativeness of the convenience sample would have been impossible to determine. Lastly, because of the blind nature of the survey distribution, we cannot assess for bias in the demographic or attitude of the respondents compared to non-respondents. Detailed demographic information regarding the entire population across all the centers is unknown; nonresponse bias could confound the results.
Conclusions
In this multi-center survey study of ED clinicians, selfreported OA prescribing decisions varied between centers and found some providers occasionally prescribe OA for non-medical reasons including expediting ED discharge and increasing patient satisfaction. The utilization of prescribing guidelines and PDMPs was not associated with any differences in OA prescribing decisions.
